Dr. Jerome P. Yatskowitz, MD

Dr. Yatskowitz practices at University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico.

Dr. Yatskowitz's NPI, 1689768079, was assigned on October 3, 2006. Dr. Yatskowitz graduated from Rutgers New Jersey Medical School in 1986. Dr. Yatskowitz holds New Mexico license 92380.

Dr. Yatskowitz's primary practice is University of New Mexico Hospital, at 2211 Lomas Boulevard NE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 272-2111.

Dr. Yatskowitz's primary practice is University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico. Dr. Yatskowitz is also affiliated with Tucson Medical Center. The medical group on file is UNM Medical Group, Inc. Dmand AI also links Dr. Yatskowitz to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yatskowitz practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Yatskowitz's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Yatskowitz is licensed in New Mexico.

CMS data shows 962 Medicare services from Dr. Yatskowitz across 15 procedure codes in 2024, for 645 Medicare patients. Medicare paid $43,105 for them.

CMS counts 645 Medicare patients who saw Dr. Yatskowitz in 2024. The largest group is 65 to 74, with 258 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yatskowitz's median patient age at 67, with 46% women.

In 2024, Dr. Yatskowitz wrote 926 Medicare Part D claims for 197 patients. 85% of them were for generic drugs. CMS names the drug for 816 of them, across 22 drugs with 11 or more claims each, at $83,720 in total drug cost. In 2023, CMS named 1,062 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Yatskowitz for performance year 2024, reported through an alternative payment model (APM). Dr. Yatskowitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 27 general payments to Dr. Yatskowitz from 13 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $257.

Dr. Yatskowitz graduated from Rutgers New Jersey Medical School in 1986.